Local recurrences of breast cancer after organ-sparing treatment: the site of oncoplastic resections and risk factors
- Authors: Zikiryakhodzhaev A.D1,2,3, Rasskazova E.A1, Omarova D.F2, Khugaeva F.S1, Ortabaeva D.R1, Tregubova A.V1, Reshetov I.V2, Kaprln A.D3,4
-
Affiliations:
- P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- Peoples’ Friendship University of Russia
- National Medical Radiology Research Center, Ministry of Health of Russia
- Issue: Vol 32, No 8 (2021)
- Pages: 5-10
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114465
- DOI: https://doi.org/10.29296/25877305-2021-08-01
- ID: 114465
Cite item
Abstract
Full Text
About the authors
A. D Zikiryakhodzhaev
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Peoples’ Friendship University of Russia
E. A Rasskazova
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia
D. F Omarova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: jiomarova@gmail.com
F. S Khugaeva
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia
D. R Ortabaeva
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia
A. V Tregubova
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia
I. V Reshetov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
A. D Kaprln
Peoples’ Friendship University of Russia; National Medical Radiology Research Center, Ministry of Health of Russia
References
- The Global Burden of Disease Cancer. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability,and Disability-Adjusted Life-Years for 29 Cancer Groups,1990 to 2017. A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 2019; 5 (12): 1749-69. doi: 10.1001/jamaoncol.2019.2996
- Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2018 году. М.: РИИС ФИАН, 2019 @@Kaprin A.D., Starinskii V.V., Petrova G.V. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2018 godu. M.: RIIS FIAN, 2019 (in Russ.)].
- Lakhtakia R. A Brief History of Breast Cancer: Part I: Surgical domination reinvented. Sultan Qaboos Univ Med J, 2014; 14 (2): e166-9.
- Payne W.S., Taylor W.F., Khonsari S. et al. Surgical Treatment of Breast Cancer. Trends and Factors Affecting Survival. Arch Surg, 1970; 101 (2): 105-13. doi: 10.1001/archsurg.1970.01340260009002
- Lukong K.E. Understanding breast cancer - The long and winding road. BBA clinical, 2017; 7: 64-77. doi: 10.1016/j.bbacli.2017.01.001
- Cotlar A.M., Dubose J.J., Rose D.M. History of surgery for breast cancer: radical to the sublime. Curr Surg, 2003; 60 (3): 329-37. doi: 10.1016/S0149-7944(02)00777-8
- Fisher B., Bauer M., Margolese R. et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med, 1985; 312 (11): 665-73. doi: 10.1056/NEJM198503143121101
- Fisher B., Redmond C., Poisson R. et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without radiation in the treatment of breast cancer. N Engl J Med, 1989; 320 (13): 822-8. doi: 10.1056/NEJM198903303201302
- Fisher B., Anderson S., Bryant J. et al. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. N Engl J Med, 2002; 347 (16): 1233-41. doi: 10.1056/NEJMoa022152
- Veronesi U., Banfi A., Saccozzi R.et al. Conservative treatment of breast cancer. A Trial in Progress at the Cancer Institute of Milan. Cancer. 1977; 39 (6 Suppl): 2822-6. doi: 10.1002/1097-0142(197706)39:6<2822::aidcncr2820390670>3.0.co;2-#
- Veronesi U., Salvadori R., Luini A. et al. Conservative Treatment of Early Breast Cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg, 1990; 211 (3): 250-9.
- Arriagada R., Le M.G., Rochard F. et al. Conservative Treatment Versus Mastectomy in Early Breast Cancer: Patterns of Failure With 15 Years of Follow-Up Data. J Clin Oncol, 1996; 14 (5): 1558-64. doi: 10.1200/JCO.1996.14.5.1558
- Litiere S., Werutsky G., Fentiman I.S. et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol, 2012; 13 (4): 412-9. doi: 10.1016/S1470-2045(12)70042-6
- Black D.M., Hunt K.K., Mittendorf E.A. Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801. Gland Surg, 2013; 2 (3): 120-3. doi: 10.3978/j.issn.2227-684X.2013.06.01
- Scholl S.M., Fourquet A., Asselain B. et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer, 1994; 30A: 645-52. doi: 10.1016/0959-8049(94)90537-1
- Fisher B., Brown A., Mamounas E. et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol, 1997; 15 (7): 2483-93. doi: 10.1200/JCO.1997.15.7.2483
- Mauriac L., MacGrogan G., Avril A. et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol, 1999; 10 (1): 47-52. doi: 10.1023/a:1008337009350
- Levy A., Borget I., Bahri M. et al. Loco-regional Control After Neo-adjuvant Chemotherapy and Conservative Treatment for Locally Advanced Breast Cancer Patients. Breast J, 2014; 20 (4): 381-7. doi: 10.1111/tbj.12277
- Cho J.H., Park J.M., Park H.S. et al. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer. J Surg Oncol, 2013; 108 (8): 531-6. doi: 10.1002/jso.23439
- Sun Y., Liao M., He L. et al. Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and metaanalysis. Medicine (Baltimore), 2017; 96 (43): e8367. DOI: 10.1097/ MD.0000000000008367
- Bertozzi N., Pesce M., Santi P.L. et al. Oncoplastic breast surgery: comprehensive review. Eur Rev Med Pharmacol Sci, 2017; 21 (11): 2572-85.
- Santos G., Urban C., Edelweiss M.I. et al. Long-Term Comparison of Aesthetical Outcomes After Oncoplastic Surgery and Lumpectomy in Breast Cancer Patients. Ann Surg Oncol, 2015; 22 (8): 2500-8. doi: 10.1245/s10434-014-4301-6
- Dogru V., Yaprak M., Durmaz E. et al. Oncoplastic approach to excisional breast biopsies: a randomized controlled, phase 2a trial. Breast Cancer, 2019; 26 (1): 84-92. doi: 10.1007/s12282-018-0892-2
- Gabka C.J., Baumeister R.G., Maiwald G. Advancements of breast conserving therapy by onco-plastic surgery in the management of breast cancer. Anticancer Res, 1998; 18 (3C): 2219-24.
- Weber W.P., Soysal S.D., Fulco I. et al. Standardization of oncoplastic breast conserving surgery. Eur J Surg Oncol, 2017; 43 (7): 1236-43. doi: 10.1016/j.ejso.2017.01.006
- Yiannakopoulou E.C., Mathelin C. Oncoplastic breast conserving surgery and oncological outcome: Systematic review. Eur J Surg Oncol, 2016; 42 (5): 625-30. doi: 10.1016/j.ejso.2016.02.002
- De La Cruz L., Blankenship S.A., Chatterjee A. et al. Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review. Ann Surg Oncol, 2016; 23 (10): 3247-58. doi: 10.1245/s10434-016-5313-1
- Clough K.B., van la Parra R.F.D., Thygesen H.H. et al. Long-term Results After Oncoplastic Surgery for Breast Cancer. A 10-year Folow-up. Ann Surg, 2017; 268 (1): 165-71. doi: 10.1097/SLA.0000000000002255
- Kaviani A., Safavi A., Mohammadzadeh N. et al. Oncoplastic surgery in breast conservation: a prospective evaluation of the patients, techniques, and oncologic outcomes. Am J Surg, 2014; 208 (5): 727-34. DOI: 10.1016/j. amjsurg.2014.04.005
- Niinikoski L., Leidenius M.H.K., Vaara P. et al. Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery. Eur J Surg Oncol, 2014; 45 (6): 976-82. DOI: 10.1016/j. ejso.2019.02.010
- Acea-Nebril B., Cereijo-Garea C., Garcia-Novoa A. et al. The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of live. J Surg Oncol, 2017; 115 (6): 679-86. doi: 10.1002/jso.24550
- Mansell J., Weiler-Mithoff E., Stallard S. et al. Oncoplastic breast conservation surgery is oncologically safe when compared to wide local excision and mastectomy. Breast. 2017; 32: 179-85. doi: 10.1016/j.breast.2017.02.006
- Kosasih S., Tayeh S., Mokbel K. et al. Is oncoplastic breast conserving surgery oncologically safe? A meta-analysis of 18,103 patients. Am J Surg, 2020; 220 (2): 385-92. doi: 10.1016/j.amjsurg.2019.12.019
- Arvold N.D., Taghian A.G., Niemierko A. et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol, 2011; 29 (29): 3885-91. doi: 10.1200/JCO.2011.36.1105
- Aalders K.C., Postma E.L., Strobbe L.J. et al. Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer. J Clin Oncol, 2016; 34 (18): 2107-14. doi: 10.1200/JCO.2015.64.3536
- Miles R.C., Gullerud R.E., Lohse C.M. et al. Local Recurrence after Breast-Conserving Surgery: Multivariable Analysis of Risk Factors and the Impact of Young Age. Ann Surg Oncol, 2011; 19 (4): 1153-9. doi: 10.1245/s10434-011-2084-6
- Maishman T., Cutress R.I., Hernandez A. et al. Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study. Ann Surg, 2017; 266 (1): 165-72. DOI: 10.1097/ SLA.0000000000001930
- Haffty B.G., Harrold E., Khan A.J. et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet. 2002; 359 (9316): 1471-7. doi: 10.1016/S0140-6736(02)08434-9
- van den Broek A.J., Schmidt M.K., van’t Veer L.J. et. al. Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients. Ann Surg, 2019; 270 (2): 364-72. doi: 10.1097/SLA.0000000000002804
- Huang X., Cai X.Y., Liu J.Q. et al. Breast-conserving therapy is safe both within BRCA1/2 mutation carriers and noncarriers with breast cancer in the Chinese population. Gland Surg, 2020; 9 (3): 775-87. doi: 10.21037/gs-20-531
- Kirova Y.M., Savignoni A., Sigal-Zafrani B. et al. Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature. Breast Cancer Res Treat. 2010; 120 (1): 119-26. doi: 10.1007/s10549-009-0685-6
- Veronesi U., Marubini E., Del Vecchio M. et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995; 87 (1): 19-27. doi: 10.1093/jnci/87.1.19
- Семиглазов В.Ф., Семиглазов В.В., Клецель А.Е. Неинвазивные и инвазивные опухоли молочной железы. СПб, 2006 @@Semiglazov V.F., Semiglazov V.V., Kletsel’ A.E. Neinvazivnye i invazivnye opukholi molochnoi zhelezy. SPb, 2006 (in Russ.)].
- Antonini N., Jones H., Horiot J.C. et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007; 82 (3): 265-71. doi: 10.1016/j.radonc.2006.09.014
- Moran M.S., Schnitt S.J., Giuliano A.E. et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014; 88 (3): 553-64. DOI: 10.1016/j. ijrobp.2013.11.012
- Lin J., Lin K.J., Wang Y.F. et al. Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy. BMC Cancer. 2020; 20 (1): 451. doi: 10.1186/s12885-020-06955-6
- Holleczek B., Stegmaier C., Radosa J.C. et al. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany. BMC Cancer. 2019; 19 (1): 520. doi: 10.1186/s12885-019-5710-5
- Ignatov A., Eggemann H., Burger E. et al. Patterns of breast cancer relapse in accordance to biological subtype. J Cancer Res Clin Oncol. 2018; 144 (7): 1347-55. doi: 10.1007/s00432-018-2644-2
- Valachis A., Mamounas E.P., Mittendorf E.A. et al. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis. Cancer. 2018; 124 (14): 2923-30. doi: 10.1002/cncr.31518
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, Correa C. et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378 (9804): 1707-16. doi: 10.1016/S0140-6736(11)61629-2
- Wickberg A., Magnuson A., Holmberg L. et al. Influence of the subtype on local recurrence risk of breast cancer with or without radiation therapy. Breast. 2018; 42: 54-60. doi: 10.1016/j.breast.2018.08.097
- Anderson W.F., Chen B.E., Jatoi I. et al. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat. 2006; 100 (1): 121-6. doi: 10.1007/s10549-006-9231-y